Clinical Trials Conditions DEA Sleep 
CannaMD
AUGUST 8, 2020
Cannabinoids (natural and plant-derived) interact with endocannabinoid receptors to regulate appetite, sleep, pain, stress, and more. For example, the DEA considers Schedule I drugs to have a “high potential for abuse and the potential to create severe psychological and/or physical dependence.” CBD Scheduling Rule Change.
SpeedWeed
MARCH 18, 2021
For Veterans With PTSD, Medical Marijuana Can Mean a Good Night’s Sleep. Given the topical nature of the current trial and its relevance for public policy on medical cannabis, participants might have been biased to report positive effects regardless of condition. Wasn’t the DEA going to let others grow research-grade cannabis?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
SpeedWeed
MARCH 5, 2021
One, they have been determined by the US Food and Drug Administration to be clinically safe and effective treatments for a specific medical condition. Two, they are federally classified by DEA and HHS as Schedule II, III, IV or V substances. Rescheduling cannabis will not necessarily facilitate clinical research.
The Cannigma
MAY 6, 2021
Technically speaking, it’s not produced by the plant, but is rather a degradation product of delta-9-THC, often as a result of aging and storage conditions. The endocannabinoid system has been shown to help regulate many key functions such as sleep, hunger, mood, immune response, and memory. That’s where it starts to get complicated.
Cannabis Law Report
MARCH 21, 2019
However, CBD will provide many medicinal benefits including reducing inflammation, pain, anxiety, stress, migraines, seizures, depression, and the ability to obtain a much deeper sleep so you can wake up well rested and ready to tackle your daily tasks. You can find the list of medical conditions here.
Expert insights. Personalized for you.
99 
Let's personalize your content